We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.91B
AUM Growth
-$58.7M
Cap. Flow
-$6.54M
Cap. Flow %
-0.34%
Top 10 Hldgs %
39.91%
Holding
252
New
15
Increased
80
Reduced
73
Closed
17

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$5.48M
2
MS icon
Morgan Stanley
MS
+$5.37M
3
PFE icon
Pfizer
PFE
+$4.76M
4
FAST icon
Fastenal
FAST
+$4.66M
5
TGT icon
Target
TGT
+$4.36M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$11.8M
3
DIS icon
Walt Disney
DIS
+$8.48M
4
LMT icon
Lockheed Martin
LMT
+$6.84M
5
TRV icon
Travelers Companies
TRV
+$3.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.07%
2 Technology 21.25%
3 Healthcare 12.53%
4 Financials 11.18%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
176
Petrobras
PBR
$123B
$491K 0.03%
33,200
TT icon
177
Trane Technologies
TT
$101B
$489K 0.03%
3,200
AMAT icon
178
Applied Materials
AMAT
$434B
$488K 0.03%
3,700
+1,100
+42% +$151K
ZS icon
179
Zscaler
ZS
$25B
$483K 0.03%
2,000
+600
+43% +$147K
ISRG icon
180
Intuitive Surgical
ISRG
$130B
$453K 0.02%
1,500
MAR icon
181
Marriott International
MAR
$90.4B
$445K 0.02%
2,534
DVN icon
182
Devon Energy
DVN
$50.8B
$438K 0.02%
7,400
-3,700
-33% -$200K
LDOS icon
183
Leidos
LDOS
$14.9B
$432K 0.02%
4,000
TSLA icon
184
Tesla
TSLA
$1.29T
$431K 0.02%
1,200
-6,900
-85% -$2.15M
CAH icon
185
Cardinal Health
CAH
$55.2B
$430K 0.02%
7,579
-4,000
-35% -$214K
TREX icon
186
Trex
TREX
$4.66B
$418K 0.02%
6,400
DD icon
187
DuPont de Nemours
DD
$19.1B
$410K 0.02%
4,434
-82
-2% -$8K
MPC icon
188
Marathon Petroleum
MPC
$89.6B
$405K 0.02%
4,740
NVS icon
189
Novartis
NVS
$292B
$395K 0.02%
4,500
-165
-4% -$14.3K
NUE icon
190
Nucor
NUE
$59.5B
$386K 0.02%
2,600
-500
-16% -$61.3K
BABA icon
191
Alibaba
BABA
$309B
$384K 0.02%
3,525
BLK icon
192
Blackrock
BLK
$175B
$382K 0.02%
+500
New +$391K
CNI icon
193
Canadian National Railway
CNI
$76.1B
$376K 0.02%
2,800
ZBRA icon
194
Zebra Technologies
ZBRA
$13.9B
$372K 0.02%
900
LLY icon
195
Eli Lilly
LLY
$995B
$344K 0.02%
1,200
EXC icon
196
Exelon
EXC
$47B
$342K 0.02%
+7,187
New +$304K
IWM icon
197
iShares Russell 2000 ETF
IWM
$83B
$341K 0.02%
1,660
OLN icon
198
Olin
OLN
$2.12B
$340K 0.02%
+6,500
New +$332K
CGNX icon
199
Cognex
CGNX
$11.9B
$339K 0.02%
4,400
NOW icon
200
ServiceNow
NOW
$122B
$334K 0.02%
+3,000
New +$336K

Similar funds

Cullinan Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Cullinan Associates held 252 positions worth $1.91B, down 3% from $1.96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q1 2022 filing shows 15 new, 80 increased, 73 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 14,000 shares worth $5.75M. The largest sale was Walmart Inc, an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q1 2022 buy was West Pharmaceutical: 14,000 shares worth $5.75M.
  • Cullinan Associates added most to Morgan Stanley in Q1 2022, an estimated $5.37M increase.
  • Cullinan Associates's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $14.5M.
  • Cullinan Associates fully exited Vontier in Q1 2022, selling an estimated $758K.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.91B portfolio in Q1 2022.
  • Cullinan Associates opened 15 new positions and closed 17 in Q1 2022.
  • Cullinan Associates's portfolio value fell 3% quarter-over-quarter to $1.91B.

Based on Cullinan Associates's 13F filing for Q1 2022, filed 21 Apr 2022.